| ID | 341 |
|---|
| No | 341 |
|---|
| Brand Name | CABOCARE 20 |
|---|
| Ingredients | CABOZANTINIB (S)-MALATE EQ.TO CABOZANTINIB 20 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | STORE BELOW 30C |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 30'S/BOTTLE |
|---|
| Dispensing Category | Prescription only |
|---|
| ATC Classification | - |
|---|
| Pharmaceutical Class | ANTINEOPLASTIC |
|---|
| Indications | FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN TREATMENT NAIVE ADULTS WITH INTERMEDIATE OR POOR RISK, IN ADULTS FOLLOWING PRIOR VASCULAR ENDOTHELIAL GROUTH FACTOR TARGETED THERAPY, AS MONOTHERAPYFOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA IN ADULTS WHO HAVE PREVIOUSLY BEEN TREATED WITH SORAFENIB |
|---|
| Contraindications | HYPERSENSITIVITY |
|---|
| Side Effects | DIARRHEA, HYPERTENTION, FATIQUE, AST INCREASED, ALT INCREASED, NAUSEA, DECREASED APPETITE |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | CAPSULE CONTAINS WHITE OR OFF WHITE POWDER |
|---|
| Note | |
|---|
| License Owner | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Manufacturer | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Country | LAO PDR |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | - |
|---|
| FDD Registration No | 03 L 0852/21 |
|---|
| FDD Registration Date | 2025-02-20 |
|---|
| Expiry Date | 2030-02-19 |
|---|
